Peran D-Dimer sebagai Penanda Sepsis Neonatorum
DOI:
https://doi.org/10.55175/cdk.v47i2.283Keywords:
D-dimer, sepsis neonatusAbstract
Sepsis merupakan penyebab utama morbiditas dan mortalitas neonatal. Disfungsi koagulasi merupakan komplikasi sepsis neonatorum yang dapat bermanifestasi klinis atau subklinis pada koagulasi intravaskular. D-dimer merupakan hasil degradasi fibrin ikat silang yang meningkat pada sepsis.
Sepsis is a major cause of neonatal morbidity and mortality. Coagulation dysfunction is a complication that can manifest clinically or subclinically in intravascular coagulation. D-dimer, a cross-linked fibrin degradation product, is increased in neonates with sepsis.
Downloads
References
Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA, et al. Considerations in the pharmacologic treatment and prevention of neonatal sepsis. Pediatr Drugs. 2014;16:67–81.
Shah BA, Padbury JF. Neonatal sepsis. Virulence. 2014;5(1):170-8.
El-Din EMRS, El-Sokkary MMA, Bassiouny MR, Hasan R. Epidemiology of neonatal sepsis and implicated pathogens: A study from Egypt. Biomed Res Int. 2015;15:1-11.
Kumar P, Chauhan A, Bhardwaj P, Chauhan L, Karol M. D-dimer: A useful marker in neonatal sepsis. J Clin Neonatol. 2015;4(2): 101-3.
Rosandi R. Korelasi kadar d-dimer dengan derajat keparahan dan lama sakit pasien urtikaria kronis [thesis]. Jakarta: Universitas Indonesia; 2014 .p. 1-44.
Mautone A, Giordano P, Montagna O, Quercia M, Altomare M, De Mattia D. Coagulation and fibrinolytic systems in the ill preterm newborn. Acta Paediatr. 1997;86:1100-4.
Gomella TL, Cunningham MD, Eyal GE. Sepsis. In: Jaszczak M, Kharidehal N, Ohyama M, Pas AT, Ramji S, Seshia M, et al, eds. Neonatology: Management, procedures, on-call problems, disease, and drugs. 7th Ed. New York: The McGraw-Hill Companies Inc; 2013 .p. 865-73.
Carolis MPD, Polimeni V, Lacerenza PPS, Romagnoli C. Severe sepsis in a premature neonate: Protein c replacement therapy. Turk J Pediatr. 2008;50: 405- 8.
Salendu PM. Sepsis neonatorum dan pneumonia pada bayi aterm. Jurnal Biomedik. 2012;4(3):175-9.
Roeslani RD. Amir I. Nasrulloh MH, Suryani. Penelitian awal faktor risiko pada sepsis neonatorum awitan dini. Sari Pediatri. 2013;14 (6): 363-8.
Hasibuan BS. Comparison of microbial pattern in early and late onset neonatal sepsis in referral center Haji Adam Malik Hospital Medan Indonesia. In: IOP Conference Series: Earth and environmental science. IOP Publishing 2018;125:1-5.
Pusponegoro TS. Sepsis pada neonatus (sepsis neonatal). Sari Pediatri. 2000;2(2):96- 102.
Nizet V, Klein JO. Bacterial sepsis and meningitis. In: Wilson CB, Nizet V, Maldonado YA, Remingron JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 8th Ed. Philadelphia: Elsevier; 2016 .p. 217-22.
Russel ARB. Neonatal sepsis. Paediatrics and Child Health. 2015;25(6):271-75.
Ahmed SAM, Salah M. Evaluation of cord blood and serum hepcidin levels as biomarkers for neonatal sepsis. AAMJ. 2015;13(3):162-8.
Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J of Pediatrics. 2008;75(3):261-6.
Effendi SH. Sepsis neonatal; Penatalaksanaan terkini serta berbagai masalah dilematis. In: Simposium ilmiah dan workshop meet the professor. Bandung: UNPAD; 2013 .p. 1-20.
Fourrier, F. Severe sepsis, coagulation, and fibrinolysis:dead end or one way? Crit Care Med. 2012;40(9):2704-8.
Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998; 26:2005–9.
Rajagopal R, Thachil J, Monagle. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. 2017;102:187-93.
Faix JD. Established and novel biomarkers of sepsis. Biomarkers Med. 2011;5(2):117-30.
Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998;26:2005–9.
Shitrit D, Izbicki G, Shitrit ABG, Kramer MR, Rudensky B, Sulkes J, et al. Prognostic value of a new quantitative d-dimer test in critically ill patients 24 and 48 h following admission to the intensive care unit. Blood Coagul and Fibrinolysis. 2004;15(1):15-9.
Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, et al. Plasma d-dimer levels correlate with outcomes in patients with communityacquired pneumonia. Chest. 2004;126(4):1087–92.
Short MA. Linking the sepsis triad of inflammation, coagulation, and suppressed fibrinolysis to infants. Advances in Neonatal Care. 2004;4(5):258-73.
Sharma A. Plasma fibrinogen and d-dimer in children with sepsis:a single-center experience. Iranian Journal of Pathology. 2018;13(02):272-5.
Levi M, Schultz M, Van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost. 2013;39(5):559-66.
Faix JD. Established and novel biomarkers of sepsis. Biomarkers Med. 2011;5(2):117-130.
Peker E, Akbayram S, Geylani H, Dogan M, Kirimi E. Global fibrinolytic capacity in neonatal sepsis. Clin Appl Thromb Hemost. 2011;17(6):64-9.
Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: Comparison with severe sepsis and septic shock. Intensive Care Med. 2001;27(12):1853-9.
Psuja P, Zozulin´ska M, Turowiecka Z, Cies´likowski W, Vinazzer H, Zawilska K. Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock. Clin Appl Thromb Hemost. 2002;8(3):225-30.
Levi M, Schultz MJ. What do sepsis-induced coagulation test result abnormalities mean to intensivists? Intensive Care Med. 2017;43(4):581–3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
